S N Atkinson Selected Research

Dexlansoprazole

2/2011	The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
11/2009	Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief.
6/2009	Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.
4/2009	Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S N Atkinson Research Topics

Disease

2	Heartburn (Pyrosis) 06/2009 - 04/2009
1	Infections 02/2011
1	Gastroesophageal Reflux (GERD) 02/2011
1	Abdominal Pain (Pain, Abdominal) 11/2009
1	Gastritis 11/2009
1	Flatulence 11/2009
1	Non-Erosive Reflux Disease 06/2009
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2009

Drug/Important Bio-Agent (IBA)

4	Dexlansoprazole FDA Link 02/2011 - 04/2009
2	Proton Pump InhibitorsIBA 02/2011 - 06/2009

Therapy/Procedure

1	Therapeutics 06/2009